Resilience-Building Interventions for Early Life Adversity
(CARE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how resilience-building interventions can improve behavior, psychosocial health, and biological responses in young children who have faced early life challenges. It tests two treatments: a Caregiver-Child Intervention, focusing on various settings and delivery methods, and Enhanced Primary Care, which supports families in connecting with social resources. Families with young children (aged 2 to 5) who have faced adversity and can access digital devices for potential telehealth sessions might be a good fit. As an unphased trial, this study offers families the chance to contribute to innovative research that could enhance support systems for young children facing adversity.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you or your child have significant medical conditions requiring treatments like immunomodulators, chemotherapy, or hormonal therapy, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the Caregiver-Child Intervention addresses early life challenges. In studies, caregivers noted that children often encountered many difficult experiences. Although these experiences can be challenging, the intervention aims to help both caregivers and children build resilience. Importantly, studies found no evidence of harm or negative effects from the intervention.
For the Enhanced Primary Care approach, which assists families in finding social support services, specific safety data is unavailable. However, because it helps families access resources, it is likely to be well-received. Generally, services that support families in this way are considered safe and helpful.
In summary, both interventions focus on providing support and building resilience. They are expected to be safe, with no known risks reported in the research.12345Why are researchers excited about this trial?
Researchers are excited about these interventions for early life adversity because they offer new ways to support both caregivers and children. The Caregiver-Child Intervention is unique because it explores different settings, like home versus clinic, and delivery methods, such as one-on-one or group sessions, to see how these factors affect outcomes. This multifaceted approach could lead to more tailored and effective support strategies. On the other hand, Enhanced Primary Care focuses on connecting families with social resources, which can address underlying social needs that often accompany early life adversity. These innovative interventions could provide more comprehensive and adaptable support than standard care options.
What evidence suggests that this trial's treatments could be effective for early life adversity?
Research shows that programs involving both caregivers and children can significantly enhance children's resilience when facing early life challenges. In this trial, participants may receive the Caregiver-Child Intervention, which helps caregivers respond more effectively to their children's needs, resulting in improved social and behavioral outcomes for the children. For example, the "Supporting Early Learning Study" found that such programs benefited both caregivers and children. Additionally, research highlights the crucial role caregivers play in helping children build resilience, especially when both have experienced difficult childhoods. Overall, these findings suggest that caregiver-child programs can effectively support children's growth in challenging situations.26789
Who Is on the Research Team?
Neeta Thakur, MD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This study is for caregivers over 18 and children aged 2-5 who have faced early life adversity. Caregivers must be the primary caregiver, speak English or Spanish, and have regular internet access. Children with significant medical conditions or caregivers with active suicidality are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive one of three resilience-promoting, caregiver-child interventions: Resilience Clinic, Attachment and Biobehavioral Catch-up, or Resiliency Family Program
Follow-up
Participants are monitored for psychosocial, behavioral, and biological outcomes after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Caregiver-child Intervention
- Enhanced Primary Care
Trial Overview
The trial tests resilience-promoting interventions in a primary care setting. It includes Enhanced Primary Care and a special program for caregiver-child interaction to improve behavioral, psychosocial, and biological outcomes related to resilience.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Investigators will examine the immediate psychosocial, behavioral, and child biologic response to three caregiver-child interventions depending on site of enrollment. Each interventions contain overlapping core elements, but also contribute unique facets, allowing us to examine overall intervention effects, as well as unique settings (e.g. home vs. clinic) and delivery effects (1:1 vs. group), providing insight for future direction.
Navigational services for social need resources.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Lifelong Medical Care
Collaborator
UCSF Benioff Children's Hospital Oakland
Collaborator
Santa Barbara Neighborhood Clinics
Collaborator
University of California, Santa Barbara
Collaborator
Futures Without Violence
Collaborator
Published Research Related to This Trial
Citations
Measuring adverse and protective experiences in early ...
The present study aimed to address current challenges in ACE measurement and screening, particularly the need for a caregiver-report tool that ...
2.
publications.aap.org
publications.aap.org/pediatrics/article/155/2/e2024068578/200622/Caregiver-and-Child-Adverse-Childhood-ExperiencesCaregiver and Child Adverse Childhood Experiences
Results of our moderator analyses suggested that the association between caregiver and child ACEs was stronger among younger vs older caregivers ...
NCT04107506 | The Supporting Early Learning Study
Aim 1: Quantify main effects of FIND on intervention targets (changes in responsive caregiving) and related caregiver and child outcomes.
Leveraging the developmental neuroscience of caregiving to ...
Here we propose that caregivers play a central role in fostering resilience among children exposed to adversity via caregiving influences.
Associations between Caregiver ACEs and Child ...
The results of these studies provide empirical support for the intergenerational link between a caregiver's early childhood adversity and their children's ...
A Caregiver-Child Intervention for Mitigating Toxic Stress ...
By study design, all caregivers reported at least one child adversity with a median report of 4 (interquartile range 1–5) adversities. Nearly ...
A data-driven approach to categorizing early life adversity ...
We employed an exploratory factor analysis to identify the factor domains of early life adversity exposure and conducted a series of regression ...
Health outcomes of adversity in early life
Three out of four children will experience at least one adverse childhood experience, and around one in five children will experience four or more adverse ...
Risk and Protective Factors | Adverse Childhood ...
A combination of factors at the individual, relationship, community, and societal levels can increase or decrease the risk of violence.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.